Showing results (41-50 of 162) with videos related to

Sort By:
Pageof 17
Drug Design, Development and Therapy|May 30, 2017
Effects of metformin extended release compared to immediate release formula on glycemic control and glycemic variability in patients with type 2 diabetesGiuseppe Derosa, Angela D'Angelo, Davide Romano, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 14, 2015
Berberis aristata/Silybum marianum fixed combination (Berberol(®)) effects on lipid profile in dyslipidemic patients intolerant to statins at high dosages: a randomized, placebo-controlled, clinical trialGiuseppe Derosa, Davide Romano, Angela D'Angelo, et al.
Phytotherapy Research : PTR|October 9, 2020
A role for quercetin in coronavirus disease 2019 (COVID-19)Giuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.
Frontiers in Endocrinology|April 25, 2022
Evaluation of the Effect on Sexual Performance of a Nutraceutical Combination Containing Alpha Lipoic Acid, Vitis vinifera L. and Ginkgo biloba, Compared to Placebo, Avanafil or a Combination of Nutraceutical Plus Avanafil in Males With Type 2 Diabetes Mellitus With Erectile DysfunctionGiuseppe Derosa, Angela D'Angelo, Paola Stefania Preti, et al.
Frontiers in Immunology|July 15, 2021
Nutraceutical Approach to Preventing Coronavirus Disease 2019 and Related ComplicationsGiuseppe Derosa, Pamela Maffioli, Angela D'Angelo, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|October 2, 2019
Ascophyllum Nodosum, Fucus Vesiculosus and chromium picolinate nutraceutical composition can help to treat type 2 diabetic patientsGiuseppe Derosa, Maria Divina Pascuzzo, Angela D'Angelo, et al.
European Journal of Gastroenterology & Hepatology|March 26, 2013
Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metforminPamela Maffioli, Elena Fogari, Angela D'Angelo, et al.
Phytotherapy Research : PTR|February 5, 2019
Ascophyllum nodosum and Fucus vesiculosus on glycemic status and on endothelial damage markers in dysglicemic patientsGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Cytokine|December 8, 2019
Adipose tissue dysfunction and metabolic disorders: Is it possible to predict who will develop type 2 diabetes mellitus? Role of markErs in the progreSsion of dIabeteS in obese paTIeNts (The RESISTIN trial)Giuseppe Derosa, Gabriele Catena, Giovanni Gaudio, et al.
Drug Design, Development and Therapy|September 11, 2018
A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patientsGiuseppe Derosa, Giovanni Gaudio, Gianfranco Pasini, et al.
Pageof 17